Skip to content
Screener

Neogen NEOG Q4 2025 Annual earnings

Reported July 29, 2025 · Before market open

Revenue$225.5MBeat by $22.8M
EPS$0.05Miss by $0.03
Revenue estimate$202.7M
EPS estimate$0.08

Next report

Date not yet announced

Financials

Q4 2025

Income statement

See full
Revenue$225.5M-4.8%
Gross profit$92.9M-18.1%
Operating income-$611.2M-4,810%
Net income-$612.2M-11,250%
EPS (diluted)-$2.82-14,000%

Balance sheet

See full
Cash & equivalents$129.0M-24.4%
Total debt$915.0M+0.7%
Total equity$2.1B-34.1%
Total assets$3.4B-24.3%

Cash flow

See full
Operating cash flow$16.4M-38.8%
CapEx$16.1M-33.6%

Valuation & ratios

Valuation

as of 05/31/25
See full
Market cap$1.33B-53.1%
Enterprise value$2.12B-40.9%
P/S1.5×-1.6×

Profitability

See full
Gross margin47.1%-3.1pp
Operating margin-118.6%-125pp
Net margin-122%-123pp

Returns & leverage

See full
Return on equity-41.9%-42.2pp
Debt / equity0.4×+0.2×
Current ratio3.3×-0.5×

Segments

By product

See full
Bacterial And General Sanitation$42.5M-0.7%
Genomics Services$22.8M-3.6%
Natural Toxins And Allergens$18.5M—
Animal Care And Other$8.0M-18.2%
Life Sciences$1.6M-10.6%

By segment

See full
Food Safety$161.8M-3.0%
Animal Safety$63.7M-8.9%

FAQ

When did Neogen report Q4 2025 earnings?
Neogen (NEOG) reported Q4 2025 earnings on July 29, 2025 before market open.
What were Neogen's Q4 2025 revenue and EPS?
Neogen reported revenue of $225.5M and eps of $0.05 for Q4 2025.
Did Neogen beat estimates in Q4 2025?
Revenue beat the consensus estimate of $202.7M by $22.8M. EPS missed the consensus estimate of $0.08 by $0.03.
How did Neogen's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 4.8% from $236.8M a year earlier and eps declined 50.0% from $0.10.
Where can I find Neogen's Q4 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-099379) and the 10-K periodic report (0000950170-25-100064) directly on SEC EDGAR. The filing index links above go to sec.gov.